Document Detail

New strategies in diagnosis and treatment of thrombotic thrombocytopenic purpura: case report and review.
MedLine Citation:
PMID:  10541941     Owner:  NLM     Status:  MEDLINE    
CONCLUSION: Assay of von Willebrand factor-cleaving protease helps to diagnose a form of thrombotic thrombocytopenic purpura which may be managed by prophylactic treatment with fresh frozen plasma.
J Häberle; B Kehrel; J Ritter; H Jürgens; B Lämmle; M Furlan
Publication Detail:
Type:  Case Reports; Journal Article; Review    
Journal Detail:
Title:  European journal of pediatrics     Volume:  158     ISSN:  0340-6199     ISO Abbreviation:  Eur. J. Pediatr.     Publication Date:  1999 Nov 
Date Detail:
Created Date:  1999-12-02     Completed Date:  1999-12-02     Revised Date:  2013-05-20    
Medline Journal Info:
Nlm Unique ID:  7603873     Medline TA:  Eur J Pediatr     Country:  GERMANY    
Other Details:
Languages:  eng     Pagination:  883-7     Citation Subset:  IM    
Klinik und Poliklinik für Anästhesiologie und operative Intensivmedizin, Westfälische Wilhelms-Universität Münster, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Blood Coagulation Tests
Blood Component Transfusion / methods*
Child, Preschool
Follow-Up Studies
Magnetic Resonance Imaging
Purpura, Thrombotic Thrombocytopenic / diagnosis*,  mortality,  therapy*
Severity of Illness Index
Survival Rate
Treatment Outcome
von Willebrand Factor / analysis*
Reg. No./Substance:
0/von Willebrand Factor

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Cystic adenomatoid malformation of the lung: clinical evolution and management.
Next Document:  Appropriate positive end expiratory pressure level in surfactant-treated preterm infants.